Randomized phase II syudy of weekly docetaxel versus S-1 and concurrent radiothrapy for stage III and IV laryngeal, oropharyngeal, and hypopharyngeal cancer in elderly patients or patients with complications - Phase II trial of concurrent chemoradiotherapy in elderly patients or patients with complications

study group of chemoradiotherapy of the head and neck cancer0 个研究点目标入组 60 人开始时间: 2008年5月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)with sever complications (for example ; malignant hypertension, congested heart failure, coronary insufficiency, myocardial infarction, angina pectoris, or abnormal cardiac rhythm which need to treat within 6 months, cerebrovascular accident within 6 months, cirrhosis, hemorrhagic gastrointestinal ulceration, diabetes that is loss of control, bleeding tendency) 2)with deverop fever and suspected infection 3)with motor palsy, peripheral neuropathy or edema (exclude the disorder which derives from primary disease) 4)with pleural effusion which need to treat or pericardial effusions 5)with active double cancer 6)pregnant or nursing women or women who like be pregnant 7)with interstitial pneumonitis which is revealed from chest X ray or chest CT 8)with a history of mental disorder or treated it at the moment 9)with sever allergy to docetaxel or S-1, or with a history of sever allergy 10)doctor's decision not to be registered to this study

发起方

study group of chemoradiotherapy of the head and neck cancer